glucose, (beta-d)-isomer has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H | 1 |
| Hatano, T; Ishimoto, H; Ito, H; Myojin, Y; Shibata, M; Sugimoto, Y; Tai, A | 1 |
1 review(s) available for glucose, (beta-d)-isomer and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
| Article | Year |
|---|---|
Metabolites of the ellagitannin geraniin and their antioxidant activities.
Topics: Animals; Antioxidants; Biphenyl Compounds; Chromatography, High Pressure Liquid; Coumarins; Free Radical Scavengers; Geranium; Glucosides; Hydrolyzable Tannins; Intestinal Mucosa; Intestines; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Picrates; Pyrones; Rats | 2011 |
1 other study(ies) available for glucose, (beta-d)-isomer and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
| Article | Year |
|---|---|
In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Discovery; Drug Evaluation, Preclinical; Edema; Free Radical Scavengers; Glucosides; Glucuronides; Humans; Hydrolyzable Tannins; Lythraceae; Mice; Mice, Inbred ICR; Rats | 2011 |